Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | 6.89% | 160.03 | 0.0% | $1347.19m | |
AMGN | Amgen, Inc. | -0.13% | 249.62 | 1.3% | $691.62m | |
NVAX | Novavax, Inc. | 3.43% | 201.34 | 80.0% | $571.11m | |
SNSS | Sunesis Pharmaceuticals, Inc. | -1.50% | 7.88 | 0.7% | $550.84m | |
ILMN | Illumina, Inc. | -1.26% | 398.07 | 3.5% | $515.02m | |
GILD | Gilead Sciences, Inc. | 0.63% | 65.30 | 1.0% | $465.35m | |
REGN | Regeneron Pharmaceuticals, Inc. | 0.86% | 481.16 | 2.7% | $431.65m | |
VRTX | Vertex Pharmaceuticals, Inc. | 0.55% | 217.13 | 1.9% | $373.76m | |
ALXN | Alexion Pharmaceuticals, Inc. | 1.02% | 155.29 | 2.0% | $316.00m | |
BIIB | Biogen, Inc. | -0.15% | 265.79 | 1.7% | $265.53m | |
BNTX | BioNTech SE | 2.28% | 132.60 | 0.0% | $236.33m | |
EXAS | EXACT Sciences Corp. | -0.67% | 127.14 | 18.4% | $192.79m | |
NBIX | Neurocrine Biosciences, Inc. | 2.24% | 95.05 | 4.9% | $177.79m | |
CRSP | CRISPR Therapeutics AG | 1.85% | 123.11 | 0.6% | $176.91m | |
TWST | Twist Bioscience Corp. | 0.87% | 142.03 | 0.0% | $150.98m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.